Objective: Resistance to immune checkpoint inhibitors (ICIs) has been a massive obstacle to ICI treatment in metastatic urothelial carcinoma (MUC). Recently. increasing evidence indicates the clinical importance of the association between hypoxia and immune status in tumor patients. Therefore. https://www.herbsdailyes.shop/product-category/5-htp-2/